LINDSEY NORMAN: Open Payments
NPI 1457753527 · MANNFORD, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 32 payments from 10 companies in 2025. Trend: 2023 $734 · 2024 $1,246 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $396 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 4 | $102 |
| GlaxoSmithKline, LLC. | 4 | $89 |
| Lilly USA, LLC | 4 | $81 |
| ABBVIE INC. | 4 | $75 |
| Dexcom, Inc. | 2 | $38 |
| Lundbeck LLC | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: AIRSUPRA, AUSTEDO XR, TRELEGY ELLIPTA, FARXIGA, VRAYLAR, BREZTRI, MOUNJARO, JARDIANCE.
Industry payments across OK — which companies pay providers there.
